BridgeBio, Armata top healthcare gainers; Aclaris, Adaptimmune among losers

Mar. 06, 2023 10:00 AM ETONCS, ESPR, ADAP, ARMP, ACRS, KALA, TCRR, BBIO, EUDA, CDIOBy: Ravikash, SA News Editor

stock market — hxdbzxy/iStock via Getty Images

Gainers: BridgeBio Pharma (BBIO) +67%. Armata Pharmaceuticals (ARMP) +23%. TCR2 Therapeutics (TCRR) +21%. Euda Health (EUDA) +12%. Kala Pharmaceuticals (KALA) +16%.
Losers: Aclaris Therapeutics (ACRS) -44%. Adaptimmune Therapeutics (ADAP) -21%. Esperion Therapeutics (ESPR) -21%. OncoSec Medical (ONCS) -14%. Cardio Diagnostics (CDIO) -7%.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.